Yi Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi Liu has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Hao Zhang
Jilin University
59 shared publications - Bai Yang
State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, China
32 shared publications Shuwei Liu
In Medicine and Chemistry Institute of Translational Medicine Joint Laboratory of Opto-Functional Theranostics The First Hospital of Jilin University 130021 Changchun China
24 shared publicationsZe Wang
State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun 130012, P. R. China
14 shared publicationsWenjie Feng
Institute of Translational Medicine The First Hospital of Jilin University Changchun P. R. China
12 shared publicationsHaoyang Zou
11 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (57) , e76677
Reversing Temozolomide Resistance in Glioblastoma Based on Cuproptosis‐Mediated Positive Feedback Loop
Glioblastoma (GBM), one of the most lethal human cancers, faces a major therapeutic challenge due to drug resistance. Temozolomide (TMZ), a standard first‐line drug for clinical GBM treatment, benefits only a subset of patients, leaving an urgent need for strategies that can restore its efficacy. Herein, we propose that cuproptosis, a recently identified regulated cell death (RCD), is capable of reversing TMZ resistance in GBM. We design copper‐TMZ (Cu‐TMZ) prodrugs, assembled via the coordination of Cu 2+ with TMZ and, in optimized formulations, co‐loaded with metformin (MET) as an AMPK activator, to exploit cuproptosis for overcoming TMZ resistance. Upon glutathione‐triggered disassembly, the prodrugs release Cu + and TMZ, inducing mitochondrial proteotoxic stress and initiating a self‐amplifying cuproptosis loop characterized by ATP depletion, AMPK‐p53 activation, and glycolysis inhibition. Beyond self‐reinforcement, cuproptosis directly potentiates TMZ activity by suppressing drug efflux, impairing DNA repair, and aggravating metabolic and redox stress. Both in vitro and in vivo experiments demonstrate that Cu‐TMZ/MET prodrugs markedly restore TMZ responsiveness and suppress TMZ‐resistant GBM progression. More broadly, this study illustrates how RCD pathways can be engineered into therapeutics to convert drug resistance into vulnerability, highlighting a generalizable strategy for improving the efficacy of frontline chemotherapy in otherwise intractable cancers.
- 20 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (57) , e76677
Open AccessReversing Temozolomide Resistance in Glioblastoma Based on Cuproptosis‐Mediated Positive Feedback Loop
Glioblastoma (GBM), one of the most lethal human cancers, faces a major therapeutic challenge due to drug resistance. Temozolomide (TMZ), a standard first‐line drug for clinical GBM treatment, benefits only a subset of patients, leaving an urgent need for strategies that can restore its efficacy. Herein, we propose that cuproptosis, a recently identified regulated cell death (RCD), is capable of reversing TMZ resistance in GBM. We design copper‐TMZ (Cu‐TMZ) prodrugs, assembled via the coordination of Cu 2+ with TMZ and, in optimized formulations, co‐loaded with metformin (MET) as an AMPK activator, to exploit cuproptosis for overcoming TMZ resistance. Upon glutathione‐triggered disassembly, the prodrugs release Cu + and TMZ, inducing mitochondrial proteotoxic stress and initiating a self‐amplifying cuproptosis loop characterized by ATP depletion, AMPK‐p53 activation, and glycolysis inhibition. Beyond self‐reinforcement, cuproptosis directly potentiates TMZ activity by suppressing drug efflux, impairing DNA repair, and aggravating metabolic and redox stress. Both in vitro and in vivo experiments demonstrate that Cu‐TMZ/MET prodrugs markedly restore TMZ responsiveness and suppress TMZ‐resistant GBM progression. More broadly, this study illustrates how RCD pathways can be engineered into therapeutics to convert drug resistance into vulnerability, highlighting a generalizable strategy for improving the efficacy of frontline chemotherapy in otherwise intractable cancers.
- 9 June 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (6) , 5106-5117
Hydrogel Microbead-Confined Nanozyme-SERS Sensor for Robust Detection of Hydrogen Peroxide in Complex Biological Systems
Inflammation-associated oxidative stress is critically involved in the initiation and progression of numerous pathological processes, yet its reliable detection in complex biological environments remains a major analytical challenge. Herein, we present a hydrogel-confined nanozyme-SERS sensing microbead platform that enables sensitive and interference-resistant detection of H2O2, a central oxidative biomarker of inflammation. Au@Pt nanozymes are encapsulated in poly(ethylene glycol) diacrylate (PEGDA) hydrogel microbeads to form size-selective microreactors with a well-defined reaction microenvironment for direct SERS readout. Within this confined architecture, the Au@Pt nanozymes efficiently catalyze the H2O2-driven oxidation of TMB to a Raman-active product, yielding pronounced signal amplification through the plasmonic Au core. The PEGDA hydrogel matrix permits the rapid diffusion of small molecular reactants while effectively excluding macromolecular interferents, thereby substantially improving signal stability and measurement reproducibility in complex biological matrices. The platform enables H2O2 detection under physiologically relevant conditions, discriminates oxidative signatures among glioma-related cell types, and allows in situ monitoring during murine wound healing. This work establishes a hydrogel-nanozyme analytical paradigm that integrates microenvironment confinement with pore-size-mediated exclusion of macromolecules, providing a generalizable strategy for robust detection of diverse analytes in complex biological systems.
- 9 June 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (6) , 5106-5117
Hydrogel Microbead-Confined Nanozyme-SERS Sensor for Robust Detection of Hydrogen Peroxide in Complex Biological Systems
Inflammation-associated oxidative stress is critically involved in the initiation and progression of numerous pathological processes, yet its reliable detection in complex biological environments remains a major analytical challenge. Herein, we present a hydrogel-confined nanozyme-SERS sensing microbead platform that enables sensitive and interference-resistant detection of H2O2, a central oxidative biomarker of inflammation. Au@Pt nanozymes are encapsulated in poly(ethylene glycol) diacrylate (PEGDA) hydrogel microbeads to form size-selective microreactors with a well-defined reaction microenvironment for direct SERS readout. Within this confined architecture, the Au@Pt nanozymes efficiently catalyze the H2O2-driven oxidation of TMB to a Raman-active product, yielding pronounced signal amplification through the plasmonic Au core. The PEGDA hydrogel matrix permits the rapid diffusion of small molecular reactants while effectively excluding macromolecular interferents, thereby substantially improving signal stability and measurement reproducibility in complex biological matrices. The platform enables H2O2 detection under physiologically relevant conditions, discriminates oxidative signatures among glioma-related cell types, and allows in situ monitoring during murine wound healing. This work establishes a hydrogel-nanozyme analytical paradigm that integrates microenvironment confinement with pore-size-mediated exclusion of macromolecules, providing a generalizable strategy for robust detection of diverse analytes in complex biological systems.
- 8 April 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 216, 333-347
Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy
- 8 April 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 216, 333-347
Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy
- 3 December 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 210, 499-515
Omeprazole-mediated nanodelivery of copper for synchronous remodeling of copper influx and efflux in cuproptotic glioblastoma therapy
- 3 December 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 210, 499-515
Omeprazole-mediated nanodelivery of copper for synchronous remodeling of copper influx and efflux in cuproptotic glioblastoma therapy
- Open Access
- 1 August 2025
- Published by Tsinghua University Press in Nano Research
Nanostructured antimicrobial peptides with cascade catalytic activity for effective treatment of MRSA-infected diabetic wounds
Diabetic wound is a severe complication of diabetes, which significantly impacts clinical management and patient quality of life due to prolonged healing times and increased susceptibility to infections, particularly by antibiotic-resistant pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA). Although novel antibiotics have been developed, their clinical use is often limited by suboptimal therapeutic efficacy and significant adverse effects. Herein, we demonstrate the effective elimination of MRSA using nanostructured antimicrobial peptides (nAMPs) derived from lysine aggregates. The nAMPs are prepared by enriching lysine on the surface of FeOOH nanoshuttles, which produces FeOOH@Fe-Lysine. The FeOOH@Fe-Lysine nAMPs integrate conventional antibiotic mechanisms with antimicrobial peptide functionalities, targeting bacterial membrane integrity, metabolic pathways, and protein synthesis. Furthermore, the decoration of ultrasmall Au nanoparticles possessing glucose oxidase-like activity enables nAMPs to catalytically produce hydroxyl radicals from glucose, effectively eliminating MRSA and disrupting its biofilms.
- 1 August 2025
- Published by Tsinghua University Press in Nano Research
Open AccessNanostructured antimicrobial peptides with cascade catalytic activity for effective treatment of MRSA-infected diabetic wounds
Diabetic wound is a severe complication of diabetes, which significantly impacts clinical management and patient quality of life due to prolonged healing times and increased susceptibility to infections, particularly by antibiotic-resistant pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA). Although novel antibiotics have been developed, their clinical use is often limited by suboptimal therapeutic efficacy and significant adverse effects. Herein, we demonstrate the effective elimination of MRSA using nanostructured antimicrobial peptides (nAMPs) derived from lysine aggregates. The nAMPs are prepared by enriching lysine on the surface of FeOOH nanoshuttles, which produces FeOOH@Fe-Lysine. The FeOOH@Fe-Lysine nAMPs integrate conventional antibiotic mechanisms with antimicrobial peptide functionalities, targeting bacterial membrane integrity, metabolic pathways, and protein synthesis. Furthermore, the decoration of ultrasmall Au nanoparticles possessing glucose oxidase-like activity enables nAMPs to catalytically produce hydroxyl radicals from glucose, effectively eliminating MRSA and disrupting its biofilms.
- Open Access
- 3 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (37) , e03164
Manipulating Liquid‐Liquid Interphase Solute Diffusion for the Construction of Non‐Symmetric Metal‐Quinone Network Nanoarchitectonics and Nano‐Motorization
Non‐symmetric nanoarchitectonics have demonstrated superior performance in nanotherapeutics compared to their symmetric counterparts, particularly in the design of self‐propelled nanodrug delivery systems. However, achieving precise morphological control of non‐symmetric nanoarchitectonics composed of molecular drugs, without the use of templates and surfactants, remains a significant challenge. In this work, a strategy is presented to construct non‐symmetric metal‐quinone network (MQN) nanoarchitectonics with controlled morphology and size by manipulating solute and solvent diffusion behaviors during the nanoprecipitation process. The findings reveal that solute diffusion at the liquid‐liquid interface of miscible solvent and antisolvent can be confined by self‐generated MQNs, which in turn dictates the morphology of the resulting nanoarchitectonics. By regulating interphase solute diffusion kinetics, a variety of MQN nanoarchitectonics are successfully produced with spherical, semifootball‐like, and bowl‐like morphologies, ranging in sizes from tens to hundred of nanometers. Notably, the non‐symmetric MQN nanobowls are further employed to create self‐propelled nanodrugs, which indicates enhanced efficacy in tumor therapy. This study underscores the critical role of liquid‐liquid interphase solute diffusion in determining the morphology and size of MQN nanoarchitectonics and highlights the potential of nanoprecipitation as a powerful technique for the precise fabrication of non‐symmetric nanoarchitectonics.
- 3 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (37) , e03164
Open AccessManipulating Liquid‐Liquid Interphase Solute Diffusion for the Construction of Non‐Symmetric Metal‐Quinone Network Nanoarchitectonics and Nano‐Motorization
Non‐symmetric nanoarchitectonics have demonstrated superior performance in nanotherapeutics compared to their symmetric counterparts, particularly in the design of self‐propelled nanodrug delivery systems. However, achieving precise morphological control of non‐symmetric nanoarchitectonics composed of molecular drugs, without the use of templates and surfactants, remains a significant challenge. In this work, a strategy is presented to construct non‐symmetric metal‐quinone network (MQN) nanoarchitectonics with controlled morphology and size by manipulating solute and solvent diffusion behaviors during the nanoprecipitation process. The findings reveal that solute diffusion at the liquid‐liquid interface of miscible solvent and antisolvent can be confined by self‐generated MQNs, which in turn dictates the morphology of the resulting nanoarchitectonics. By regulating interphase solute diffusion kinetics, a variety of MQN nanoarchitectonics are successfully produced with spherical, semifootball‐like, and bowl‐like morphologies, ranging in sizes from tens to hundred of nanometers. Notably, the non‐symmetric MQN nanobowls are further employed to create self‐propelled nanodrugs, which indicates enhanced efficacy in tumor therapy. This study underscores the critical role of liquid‐liquid interphase solute diffusion in determining the morphology and size of MQN nanoarchitectonics and highlights the potential of nanoprecipitation as a powerful technique for the precise fabrication of non‐symmetric nanoarchitectonics.
- 17 February 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 13 (13) , 6547-6555
Flexible organic crystal-quantum dot hybrids with adjustable waveguides
Organic crystals integrate multicolor emissions from semiconductor quantum dots via a modular assembly approach. This modular strategy merges the advantages of quantum dots and organic crystals for versatile photonics.
- 17 February 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 13 (13) , 6547-6555
Flexible organic crystal-quantum dot hybrids with adjustable waveguides
Organic crystals integrate multicolor emissions from semiconductor quantum dots via a modular assembly approach. This modular strategy merges the advantages of quantum dots and organic crystals for versatile photonics.
- Open Access
- 18 November 2024
- Published by Wiley in Advanced Science
- Vol. 12 (2) , e2413201
Nanoengineering of Phosphate/Phosphonate Drugs via Competitive Replacement with Metal‐Phenolic Networks to Overcome Breast Tumor with Lung and Bone Metastasis
Phosphate and phosphonate drugs are vital in building organisms, regulating physiological processes, and exhibiting diverse biological activities, including antiviral, antibacterial, antineoplastic, and enzyme‐inhibitory effects. However, their therapeutic potential is limited by the lack of advanced nanoengineering technologies. Herein, a competitive coordination strategy for nanoengineering phosphate/phosphonate drugs is introduced. By leveraging the difference in coordination capabilities between polyphenols and phosphates/phosphonates with metal ions, various phosphate/phosphonate‐based nanodrugs using metal‐phenolic networks (MPNs) as templates and phosphate/phosphonate drugs as competitive agents are constructed. The dynamic nature of these coordination bonds imparts stimuli‐responsiveness to the nanodrugs, allowing for targeted release and therapy. As a proof of concept, Fe3+ and galangin are used to form the MPN template, zoledronic acid and cGAMP as competitive agents, and DOX as the loaded drug to construct DOX@Fe‐galangin@Fe‐zoledronic acid‐cGAMP nanodrugs. The results demonstrate that, by triggering pyroptosis and activating the cGAS‐STING pathway, the nanodrugs exhibit potent cytotoxicity and accurate selectivity in eradicating orthotopic breast tumors, and activate an antitumor immune response against lung and bone metastases. Because the competitive coordination strategy is applicable to a variety of phosphate/phosphonate agents, it holds significant potential for enhancing the clinical efficacy of phosphate/phosphonate drugs and advancing nanodrug development for complex therapeutic applications.
- 18 November 2024
- Published by Wiley in Advanced Science
- Vol. 12 (2) , e2413201
Open AccessNanoengineering of Phosphate/Phosphonate Drugs via Competitive Replacement with Metal‐Phenolic Networks to Overcome Breast Tumor with Lung and Bone Metastasis
Phosphate and phosphonate drugs are vital in building organisms, regulating physiological processes, and exhibiting diverse biological activities, including antiviral, antibacterial, antineoplastic, and enzyme‐inhibitory effects. However, their therapeutic potential is limited by the lack of advanced nanoengineering technologies. Herein, a competitive coordination strategy for nanoengineering phosphate/phosphonate drugs is introduced. By leveraging the difference in coordination capabilities between polyphenols and phosphates/phosphonates with metal ions, various phosphate/phosphonate‐based nanodrugs using metal‐phenolic networks (MPNs) as templates and phosphate/phosphonate drugs as competitive agents are constructed. The dynamic nature of these coordination bonds imparts stimuli‐responsiveness to the nanodrugs, allowing for targeted release and therapy. As a proof of concept, Fe3+ and galangin are used to form the MPN template, zoledronic acid and cGAMP as competitive agents, and DOX as the loaded drug to construct DOX@Fe‐galangin@Fe‐zoledronic acid‐cGAMP nanodrugs. The results demonstrate that, by triggering pyroptosis and activating the cGAS‐STING pathway, the nanodrugs exhibit potent cytotoxicity and accurate selectivity in eradicating orthotopic breast tumors, and activate an antitumor immune response against lung and bone metastases. Because the competitive coordination strategy is applicable to a variety of phosphate/phosphonate agents, it holds significant potential for enhancing the clinical efficacy of phosphate/phosphonate drugs and advancing nanodrug development for complex therapeutic applications.
- 8 November 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (46) , 31846-31868
Nutritional Glutamine-Modified Iron-Delivery System with Enhanced Endocytosis for Ferroptosis Therapy of Pancreatic Tumors
Heterogeneous reprogrammed nutrient metabolic networks formed by oncogenes exhibit the potential for exploring novel druggable targets and developing innovative anticancer therapeutics. Herein, based on the heterogeneous metabolic characteristics of glutamine (Gln) addiction in pancreatic cancer cells, an iron-delivery system (IDS) with enhanced endocytosis is designed for efficient ferroptosis therapy. The IDS is characterized by Gln modification and can be recognized as a source of Gln nutrients for efficient endocytic uptake by pancreatic tumor cells. Because the IDS is flexible to combine with amino acid-like components, the IDS with enhanced endocytosis is further produced by loading the Gln transporter inhibitor of V9302. V9302 is capable of suppressing molecular Gln uptake via transporter ASCT2, which generates Gln deprivation to direct metabolic reprogramming of cancer cells and enhances cellular uptake of Gln-modified IDS via RAS-stimulated macropinocytosis. The enhanced endocytosis and high iron content of IDS facilitate ferroptosis in mice pancreatic tumor models; thus, an amino acid-like ferroptosis inducer of l-buthionine sulfoximine (BSO) is further combined. The enhanced endocytosis resulting from the synergism of Gln and V9302 enables the efficient delivery of iron and BSO for ferroptosis tumor therapy. This work provides an alternative approach for enhancing intracellular drug delivery of the tumors with heterogeneous nutrient metabolism by virtue of combining nutrient-modified nanodrugs with the corresponding nutrient transporter inhibitors.
- 8 November 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (46) , 31846-31868
Nutritional Glutamine-Modified Iron-Delivery System with Enhanced Endocytosis for Ferroptosis Therapy of Pancreatic Tumors
Heterogeneous reprogrammed nutrient metabolic networks formed by oncogenes exhibit the potential for exploring novel druggable targets and developing innovative anticancer therapeutics. Herein, based on the heterogeneous metabolic characteristics of glutamine (Gln) addiction in pancreatic cancer cells, an iron-delivery system (IDS) with enhanced endocytosis is designed for efficient ferroptosis therapy. The IDS is characterized by Gln modification and can be recognized as a source of Gln nutrients for efficient endocytic uptake by pancreatic tumor cells. Because the IDS is flexible to combine with amino acid-like components, the IDS with enhanced endocytosis is further produced by loading the Gln transporter inhibitor of V9302. V9302 is capable of suppressing molecular Gln uptake via transporter ASCT2, which generates Gln deprivation to direct metabolic reprogramming of cancer cells and enhances cellular uptake of Gln-modified IDS via RAS-stimulated macropinocytosis. The enhanced endocytosis and high iron content of IDS facilitate ferroptosis in mice pancreatic tumor models; thus, an amino acid-like ferroptosis inducer of l-buthionine sulfoximine (BSO) is further combined. The enhanced endocytosis resulting from the synergism of Gln and V9302 enables the efficient delivery of iron and BSO for ferroptosis tumor therapy. This work provides an alternative approach for enhancing intracellular drug delivery of the tumors with heterogeneous nutrient metabolism by virtue of combining nutrient-modified nanodrugs with the corresponding nutrient transporter inhibitors.
- Open Access
Boosting disassembly of π–π stacked supramolecular nanodrugs under tumor microenvironment by introducing stimuli‐responsive drug‐mates
Numerous reports have demonstrated the construction of supramolecular nanodrugs (SNDs) via the π–π stacking of drug molecules for antitumor applications because most drugs possess aromatic rings or other planar conjugate units. However, the destruction of π–π stacking and the subsequent disassembly of SNDs under tumor microenvironment (TME), which is the precondition for drug release, have not been clearly described. In this work, based on a disassembly model of π–π stacked naphthoquinone SNDs, the influence of co‐assembled drugs on disassembly is delineated. Both the experimental observation and computational simulation indicate that the disassembly of SNDs under simulated TME highly depends on the disassembly activation energy (ΔEdis) of neighboring π–π stacked molecules. Owing to the high ΔEdis, the disassembly of self‐assembled naphthoquinone SNDs is greatly restricted. Meaningfully, the ΔEdis is the sum of a series of activation energy according to the specific stimuli of TME. Thus, a concept of stimuli‐responsive drug‐mates is proposed for boosting the disassembly of π–π stacked SNDs, namely the foremost co‐assembly of π‐conjugated drugs with additional drug molecules that possess relatively weak π–π interaction but high TME responsiveness. Further computational simulation reveals that the introduction of stimuli‐responsive drug‐mates significantly lowers the ΔEdis, thus accelerating the disassembly of SNDs and the release of drug payloads. Holding the advantages of π‐conjugated drug library, the concept of stimuli‐responsive drug‐mates gives an extensive design of π–π stacked SNDs toward heterogeneous nidus microenvironment responsiveness, which highlights the superiority of widely used drug co‐assembly strategy in constructing multifunctional SNDs.
Open AccessBoosting disassembly of π–π stacked supramolecular nanodrugs under tumor microenvironment by introducing stimuli‐responsive drug‐mates
Numerous reports have demonstrated the construction of supramolecular nanodrugs (SNDs) via the π–π stacking of drug molecules for antitumor applications because most drugs possess aromatic rings or other planar conjugate units. However, the destruction of π–π stacking and the subsequent disassembly of SNDs under tumor microenvironment (TME), which is the precondition for drug release, have not been clearly described. In this work, based on a disassembly model of π–π stacked naphthoquinone SNDs, the influence of co‐assembled drugs on disassembly is delineated. Both the experimental observation and computational simulation indicate that the disassembly of SNDs under simulated TME highly depends on the disassembly activation energy (ΔEdis) of neighboring π–π stacked molecules. Owing to the high ΔEdis, the disassembly of self‐assembled naphthoquinone SNDs is greatly restricted. Meaningfully, the ΔEdis is the sum of a series of activation energy according to the specific stimuli of TME. Thus, a concept of stimuli‐responsive drug‐mates is proposed for boosting the disassembly of π–π stacked SNDs, namely the foremost co‐assembly of π‐conjugated drugs with additional drug molecules that possess relatively weak π–π interaction but high TME responsiveness. Further computational simulation reveals that the introduction of stimuli‐responsive drug‐mates significantly lowers the ΔEdis, thus accelerating the disassembly of SNDs and the release of drug payloads. Holding the advantages of π‐conjugated drug library, the concept of stimuli‐responsive drug‐mates gives an extensive design of π–π stacked SNDs toward heterogeneous nidus microenvironment responsiveness, which highlights the superiority of widely used drug co‐assembly strategy in constructing multifunctional SNDs.